Mandibular Sequential Distalization Versus Class III Elastics With Clear Aligners in Class III Patients
Launched by SAINT CAMILLUS INTERNATIONAL UNIVERSITY OF HEALTH SCIENCES · Mar 3, 2025
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
Class III malocclusion is considered one of the most challenging maxillofacial disorders in clinical practice characterized by an antero-posterior discrepancy with mandibular protrusion, maxillary retrusion, or a combination of both. In adult patients, managing this condition is further complicated by the absence of residual skeletal growth, limiting therapeutic options to orthodontic interventions and, in some cases, surgical procedures. Diagnosis in Class III adult patients requires distinguishing between skeletal malocclusion and dento-alveolar discrepancy. The combination of orthognathi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult age (≥19 years)
- • permanent dentition including second permanent molars
- • skeletal Class I or slight Class III (-2° \< ANB \< +2°)
- • normal skeletal divergency pattern (SN\^GoGn, 27°-37°)
- • Class III canine and molar relationship at baseline (T0), moderate lower arch crowding (≤ +4 mm)
- • good compliance with aligners and elastics (≥ 20 hours/day)
- Exclusion Criteria:
- • severe skeletal Class III malocclusion (ANB \< -2°)
- • transversal maxillary deficiency
- • use of Temporary Anchorage Devices (TADs)
- • extraction treatments other than third molars
- • periodontal disease or temporomandibular disorders (TMDs).
About Saint Camillus International University Of Health Sciences
Saint Camillus International University of Health Sciences is a distinguished academic institution dedicated to advancing healthcare education and research. With a strong emphasis on innovative clinical practices and interdisciplinary collaboration, the university fosters an environment conducive to groundbreaking clinical trials and studies. Its commitment to excellence in health sciences is reflected in its rigorous training programs and partnerships with healthcare organizations, aimed at improving patient outcomes and contributing to the global body of medical knowledge. Through its clinical trials, the university seeks to address critical health challenges and promote evidence-based therapies that enhance the quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported